Fmoc-L-beta-HAsn(Trt)-OH

Online Inquiry

CAT#CP25705
CAS283160-20-3
Synonyms/AliasFmoc-beta-Hoasn(Trt)-OH;283160-20-3;Fmoc-beta-Homoasn(Trt)-OH;FMOC-L-BETA-HOMOASPARAGINE(TRT);Fmoc-beta-Gln(Trt)-OH;(3S)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-[tri(phenyl)methylamino]pentanoicacid;Nbeta-Fmoc-Ndelta-trityl-L-homoasparagine;(S)-3-(Fmoc-amino)-N-trityl-valericacid5-amide;AmbotzFAA6640;Fmoc-?-HoAsn(Trt)-OH;Fmoc-|A-HoAsn(Trt)-OH;18505_ALDRICH;Fmoc-L-?-Homoasparagine(Trt);AC1MC547;18505_FLUKA;CTK8B3662;MolPort-003-793-982;ZINC4240251;CF-322;AKOS015948692;RTR-012515;AK-89142;KB-277021;ST24047235;(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-(tritylamino)pentanoicacid
Chemical NameN-beta-(9-Fluorenylmethyloxycarbonyl)-N-gamma-trityl-L-homoasparagine
M.F/FormulaC39H34N2O5
M.W/Mr.610.7
ApplicationPeptide synthesis; Drug screening
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

Trifluoroacetyl tripeptide-2 (TFA-T2) is an innovative peptide compound that has garnered significant attention in dermatolog ...

 Zonisamide, sold as brand name Zonegran, is a derivative of 3-(sulfamoylmethyl)-l,2-benzisoxazole. It is a membe ...

 JIP1, a member of the JIPs family, was first discovered to promote JNK activation by combining multiple componen ...

 Teriparatide is a human parathyroid hormone analog with the same structure as the N-terminal 34 amino acid seque ...

  BIM 189 is one of the most potent bombesin antagonists known in the guinea pig and 3T3 cell systems but has 40% ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.